Detalhe da pesquisa
1.
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
Nat Commun
; 14(1): 630, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746967
2.
The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.
Nat Commun
; 13(1): 1450, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304457
3.
Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers.
Nat Commun
; 13(1): 1936, 2022 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383193